Propargyl-PEG2-bromide is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

Bromo-PEG1-NH2 hydrobromide is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

Bis2-bromoethyl ether is an alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs.

Bromoacetic-PEG2-NHS ester is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

Bromoacetamido-PEG8-t-butyl acetate is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

Azido-PEG3-MS is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

Azido-PEG6-MS is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

Azido-PEG36-NHS ester is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

Benzyl-PEG24-azide is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

Azido-PEG23-C2-azide is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

Azido-PEG20-Boc is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

Azido-PEG13-azide is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

Azido-PEG13-acid is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

Benzyl-PEG13-azide is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

Azido-PEG12-THP is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

Azido-PEG11-CH2COOH is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

Azido-PEG10-azide is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

Benzyl-PEG8-azide is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

Azido-PEG8-THP is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

Azido-PEG7-CH2COOH is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

Azido-PEG1 is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

endo-BCN-PEG12-NH2 hydrochloride is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

GIP (1-30) amide, porcine TFA is a full glucose-dependent insulinotropic polypeptide (GIP) receptor agonist with high affinity equal to native GIP(1-42). GIP (1-30) amide, porcine is a weak inhibitor of gastric acid secretion and potent stimulator of insulin.

GIP, human TFA is thought to act as an inhibitor of gastric functions. GIP, human TFA, a peptide hormone consisting of 42 amino acids, is a weak inhibitor of gastric acid secretion and a potent stimulator of insulin post meals.

HBDDE, a derivative of Ellagic acid, is an isoform-selective PKCα and PKCγ inhibitor with IC50s of 43 μM and 50 μM, respectively. HBDDE shows selective for PKCα/PKCγ over PKCδ, PKCβI and PKCβII isozymes. HBDDE induces neuronal apoptosis.

KRAS inhibitor-10 selectively and effectively inhibit RAS proteins, and particularly KRAS proteins. KRAS inhibitor-10 is an orally active anti-cancer agent and can be used for cancer research, such as pancreatic cancer, breast cancer, multiple myeloma, leukemia and lung cancer. KRAS inhibitor-10 is a tetrahydroisoquinoline compound (compound 11) extracted from patent WO2021005165 A1.

RAS/RAS-RAF-IN-1 is a potent RAS and RAS-RAF inhibitor. RAS/RAS-RAF-IN-1 has a KD of 5.0 μΜ-15 μΜ for cyclophilin A (CYPA) binding affinity. RAS/RAS-RAF-IN-1 has antitumor activity.

p38α inhibitor 2 is a highly potent and selective p38α MAPK inhibitor, with a pIC50 of 9.6. p38α inhibitor 2 inhibits the hERG ion channel (IC50=27 μM) and shows a promising selectivity profile when tested in a panel of 51 other protein kinases (<30% inhibition at 10 μM concentration) and a panel of 141 other biological targets.

PI3Kα-IN-4 is a potent, selective and orally active inhibitor of PI3Kα, with an IC50 of 1.8 nM. PI3Kα-IN-4 has antitumor activity.

(S)-PI3Kα-IN-4 is a potent inhibitor of PI3Kα, with an IC50 of 2.3 nM. (S)-PI3Kα-IN-4 shows 38.3-, 4.25-, and 4.93-fold selectivity for PI3Kα over PI3Kβ, PI3Kδ, and PI3Kγ, respectively. (S)-PI3Kα-IN-4 can be used for the research of cancer.